Dr Jude A. Oben

Dr Jude Oben is a leading consultant hepatologist based in London who holds additional consultant appointments in gastroenterology. His areas of hepatology expertise include autoimmune liver disease, primary biliary cholangitis, primary sclerosis cholangitis, hepatocellular cancer, obesity, non-alcoholic fatty liver disease (NAFLD) now referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), abnormal liver function test and endoscopy and metabolic endoscopy (Intra-gastric balloon) for weight loss.

Dr Oben has a PhD in Pharmacology from University College London. He studied Medicine at Oxford with a period at Stanford University, Palo Alto, USA, as a research fellow in Immunology. After Oxford, his initial Postgraduate Medical training was at the Hammersmith Hospital, Imperial College London, followed by training in Ophthalmology (Eye Surgery) which he left for Hepatology (Liver Medicine). During his specialist medical registrar training, he re-oriented his research career with two years as a postdoctoral fellow at John Hopkins University, USA.

At Johns Hopkins, Dr Oben combined his previous interest in neuroscience with liver medicine, with a particular focus on obesity-related liver disease (NAFLD). After his time at John Hopkins, he was awarded a Wellcome Trust Fellowship in London to start independent research at University College London. He is currently an Associate Professor in Hepatology at University College London, Institute for Liver and Digestive Health, Royal Free Hospital, London.

Dr Oben is a co-founder and Trustee of the Obesity Action launched at the House of Lords. The primary aim of Obesity Action is to raise political and public awareness of obesity and it’s health consequences. He is an invited member of the All-Party Parliamentary Group on Obesity.